BioCentury
ARTICLE | Clinical News

Evolva Holding preclinical data

March 7, 2011 8:00 AM UTC

In mouse and ferret models of influenza, twice-daily oral EV-077 administered 1 day post-exposure was superior to Tamiflu oseltamivir in reducing the incidence of lung consolidation (20% vs. 30%) and...